Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefit of radioiodine therapy in thyroid cancer with neck extension and metastasis
RBR-7fy9gssPhase 3Recruiting
- Sponsor
- Fundação Faculdade de Medicina
- Start
- Jan 2017
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iodine-131 and levothyroxine sodium in thyroid cancer, papillary thyroid cancer (PTC) and well-differentiated thyroid cancer (WDTC) (4 arms), sponsored by Fundação Faculdade de Medicina. Primary endpoint: Primary endpoint not reported. Started Jan 2017; status: recruiting.
02
Drugs
iodine-131levothyroxine sodium
03
Conditions
thyroid cancerpapillary thyroid cancer (PTC)well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on RBR-7fy9gss.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7fy9gss.